TCF7L2 and hepatocellular carcinoma: The down-regulation of insulin signaling and PPARα transcription in this analysis reflects the increased expression of gluconeogenesis and lipid synthesis and trafficking genes in the hepatoma cells following Tcf7l2 silencing, as both a negative regulators of these pathways.